|
 |
|
 |
|
  |
| |
Oneness comes from the Chinese philosophy of life – the union of human and nature, emphasizing that "people live in concert with the world and work in a corresponding way with seasons " to represent the spirits of respecting nature and loving human, and convert into the management philosophy -- Value Innovation and Care for Life. |
| |
|
| |
Oneness Biotech was established in June 2008 and approved by the Government as a biopharma company. Oneness is actively engaged in the development of new drugs. Developing items include 1) WH-1, with approvals of DOH, Taiwan and FDA, US, is currently conducting Phase II clinical studies targeting wound healing of diabetic foot wounds (Diabetic foot ulcer); 2) CLEC5A antibody drug, currently at development stage of preclinical studies, is putatively the first drug around the world that may prevent and cure dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS); 3) WH-2 and RA-1, targeting atopic dermatitis (AD ) and rheumatoid arthritis (RA), respectively, are currently in the development stage of new drug discovery; and 4) a new compound from Antrodia cinnamomea (AC), which possesses anticancer and immunomodulatory functions, is also under the development stage of new drug discovery. |
| |
|
| |
In addition to development of new drugs, Oneness Biotech applies the technology platforms to develop products focusing on health care – herbal creams for skin care and glucosamine drink for cartilage care, which are currently on the market. In addition, Antrodia cinnamomea, the new member of Oneness’s pipeline, has being planned to develop related products for healthcare. Oneness Biotech, based on solid profitability, progressively achieve the goal of developing new drugs. |
| |
|
|
|
|
|
 |
|
 |
|
|
